Is risk-based clinical trial monitoring too flexible for the regulators? episode artwork

EPISODE · Nov 12, 2012 · 4 MIN

Is risk-based clinical trial monitoring too flexible for the regulators?

from Outsourcing-Pharma Podcast · host William Reed Ltd

Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.

Episode metadata supplied by the publisher feed · Published Nov 12, 2012

Embed this episode

NOW PLAYING

Is risk-based clinical trial monitoring too flexible for the regulators?

0:00 4:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Outsourcing-Pharma Podcast?

This episode is 4 minutes long.

When was this Outsourcing-Pharma Podcast episode published?

This episode was published on November 12, 2012.

Can I download this Outsourcing-Pharma Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!